FDA Drug Recalls

Recalls / Class III

Class IIID-0627-2017

Product

Nifedipine Extended-Release Tablets, 30 mg, 100-count bottles, Rx Only, Manufactured for Alvogen Inc. Pine Brook, NJ 07058 USA, NDC 47781-368-01.

Affected lot / code info
Lot #: BXH1P22, BXH1P21A, BXH1P21, BXH1P31, BXH1P21B, Exp. 11/2017; BXH6EL1, BXH66A1, BXH6EN1, BXH6EP1, BXH6ER1, Exp. 06/2018; BXH81K1A, BXHBJD1A, Exp. 10/2018

Why it was recalled

Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib

Recalling firm

Firm
Alvogen, Inc
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
10 Bloomfield Ave Bldg B Ste 2, N/A, Pine Brook, New Jersey 07058-9743

Distribution

Quantity
N/A
Distribution pattern
Nationwide

Timeline

Recall initiated
2017-03-07
FDA classified
2017-04-04
Posted by FDA
2017-04-12
Terminated
2017-12-15
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0627-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.